Abstract
PURPOSE: Smoking and obesity are modifiable risk factors that have been associated with a higher prevalence of asthma, more severe asthma, and worse asthma control. These two risk factors have also been found to be associated with a reduction in the effectiveness of inhaled corticosteroids (ICS), potentially leading higher prescribed doses. To our knowledge, no study has assessed the joint impact of smoking and obesity on ICS dose The present study assessed the interaction of smoking and obesity on prescribed ICS dose in adult asthmatics.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
